by David Cassak
Nearly 10 years ago, Dr. Gerhard Buess, one of Europe's leading proponents of minimally-invasive surgery (MIS), was being interviewed by...
Interest in surgical robotics is booming in Europe, outpacing the US. Leading the charge are two US companies; Europeans have been reluctant to commercialize new technologies and create companies. But before robotics can fulfill its apparent promise, it will have to address hospitals' cost concerns, win over conservative mainstream surgeons,and, most importantly, prove that it represents a clinically superior approach to surgery.
by David Cassak
Nearly 10 years ago, Dr. Gerhard Buess, one of Europe's leading proponents of minimally-invasive surgery (MIS), was being interviewed by...
BMS has launched a new cancer drug access program for low-to-middle income countries, focusing on addressing health inequities and widening accessibility.
Taylor Wessing investment partners share their thoughts about market trends, the surge in AI interest and the new UK government’s approach to the life sciences agenda.
The recent Women in Advanced Therapies Global event, delivered via an interactive 24-hour platform, hosted a number of biopharma speakers who drew on personal and industry-wide experiences, all aligned by a desire to break biases.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.